Please select the option that best describes you:
Topics:
Hematologic Malignancies • Medical Oncology • Lymphoma • Hodgkin Lymphoma • Internal Medicine • Hematology
Would you consider use of upfront BV plus nivolumab to treat Hodgkin Lymphoma in elderly patients unable to receive standard chemotherapy?
Are there other regimens you employ for patients unsuitable for standard chemotherapy?
Answer from: Medical Oncologist at Academic Institution
I would definitely consider BV/Nivo in frontline settings for elderly patients if no trial is available.Prognosis is worse in elderly HL for several reasons - SOC chemotherapy is not well tolerated and biology of the disease is different (mixed cellularity being prevalent and more frequent EBV posit...
Sign in or Register to read more